Prostate cancer is a significant health concern for men globally, with rising incidence and mortality rates. Early detection ...

In the observational literature, studies have consistently demonstrated that elderly men with locally advanced or high-risk prostate cancer benefit from treatment. 1, 2, 5, 6, 26 – 28 A long-term ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Prostate cancer often shows no early signs. An oncologist shares key symptoms men should watch for and treatment options that can improve outcomes.

This is the message being pushed by Dermot Murnaghan, the BBC News presenter and ITN legend who revealed this week that he ...

(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to a Radiopharmaceutical Therapy Trials with Dosimetry session. Dr.

FDA approves updated labeling for Talzenna plus Xtandi in men with HRR gene-mutated metastatic prostate cancer, showing a ...

We have a separate page about prostate cancer that has broken through the capsule (covering) of the prostate gland. Some people call this locally advanced prostate cancer. Read about locally advanced ...

Approval was based on results from the Phase II TROPION-Lung05 trial, which showed that Datroway demonstrated a strong ...

Deregulation of the retinoblastoma (RB) pathway is commonly found in virtually all known human tumors. p16, the upstream regulator of RB, is among the most commonly affected member of this pathway. In ...

In a bold step toward affordable, locally-driven cancer treatment, the Uganda Cancer Institute (UCI) has announced the ...

FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.